Who We Are
Everest is a quality and data-driven Contract Research Organization (CRO) delivering comprehensive clinical trial support to pharmaceutical, biotech and medical device companies worldwide.
We began more than 20 years ago as a 13-person biometrics consultancy serving a handful of pharmaceutical customers. Since then, we have grown to more than 700 employees globally and have earned a top-tier reputation in the industry for our quality, exceptional customer service, and “can-do” spirit.
Today, we are proud to provide full-service CRO support, including regulatory strategy, clinical operations, biometrics, IRT/RTSM, eCOA technology, pharmacovigilance, and medical writing services.
While our capabilities and reach have expanded, our commitment to excellence remains. We continue to combine quality-focused infrastructure, high-touch customer service, and motivated teams with extensive therapeutic area expertise to deliver start-to-finish trial services with speed and quality at every step.
The Everest Difference
At Everest, we set a high bar for operational excellence. Our rigorous processes— built with regulatory submissions in mind— drive quality, optimize cost-effectiveness and speed. Trusted by leading pharmaceutical companies and embraced by agile biotechs looking to minimize delivery and timeline risks, our quality sets us apart.
High-touch, responsive, and “can do” customer service is a core part of our culture and reputation. We take a customized, client-first approach to meet the unique needs of each study. We strive to meet demanding timelines, bring solutions to the table, and act with a sense of urgency. We build long-term partnerships with our clients —nearly all of our growth is fueled by our ever-growing base of repeat customers and their referrals.
We bring flexibility in our support of clients. No ask or work scope is too small, and we routinely develop unique contracting/support models tailored to your specific needs. We also strive to accommodate your preferences and help solve difficult challenges with thoughtful and pragmatic solutions based on our extensive experience driving novel and innovative projects.
Our exceptional results are driven by high-caliber teams. Everest team members are meticulously selected through an extensive evaluation process to hire the most suitable candidates. This, paired with Everest’s quality culture, processes, training, and management commitment drives a collegial, achievement-oriented and reliable workforce that is focused on advancing life-changing research.
Our Values
Our values guide how we work—both with our clients and each other. They are the foundation of our culture and the standards we hold ourselves to every day.
Consistency
We deliver reliable, high-quality results across every project, every time.
Compassion
We foster empathy and respect in our interactions, recognizing the human impact of the work we do.
Competence
We bring deep expertise, professionalism, and a “can-do” approach to every challenge.
Commitment
We have an unwavering dedication to helping our clients succeed.
Our Mission
Quality is at the heart of everything we do.
It’s our mission to go above and beyond for our clients—providing clinical research services with quality, flexibility and exceptional customer service—so our clients can meet their milestones confidently and efficiently.
Our History: A Legacy of Growth & Excellence
Since 2004, Everest Clinical Research has been on a journey of continuous growth and innovation. From a strong foundation in statistics and data management, we have expanded our services, global footprint, and expertise—establishing Everest as a trusted, global, full-service CRO.
2004
Inception
Everest begins operations with 13 employees, building a strong reputation in statistics, programming and data management.
2008
U.S. Expansion
We establish a U.S. presence in New Jersey, a key hub for our biotech and pharmaceutical clients.
2010
Launched Additional Clinical Trial Services
In response to client needs and through continuous service innovation, Everest expanded its capabilities and began providing IRT/RTSM, medical writing, regulatory operations, pharmacovigilance, and DSMB/DMC services on a regular basis.
2015
Full-service Execution with Clinical Operations
Everest launches clinical operations to round out our full-service offering, focused on complex and specialized indications including oncology, neurology, nephrology, ophthalmology, etc.
2018
Expansion to China
We extend our global reach by opening a subsidiary office in Shanghai, China.
2020
Majority Investment in Everest
We embark on a majority investment partnership with Arlington Capital Partners, fueling further growth and capabilities.
2022
Everest Acquires Brightech International
Everest expands into Taiwan and further into New Jersey through the acquisition of Brightech International.
2023
Everest Acquires August Research
The acquisition of August Research facilitates an expansion into 14 countries across western and eastern Europe to strengthen our global clinical delivery capabilities.
2024
Everest Celebrates 20 Years of Success!
We’re proud to have been serving our clients in the pharma and biotech industries for the past 20 years and look forward to many more successful years ahead.
Irene Zhang, M.Sc.
Founder and Executive Chairman
Jin Dai, H.B.A., B.Sc.
Chief Executive Officer
Rob Woolson, J.D., M.S.
Chief Operating Officer
Ghazala Parvez, MBA, BA, CA, CPA
Chief Financial Officer
Dana Leff Niedzielska, B.Sc., MBA
Senior Vice President, Global Clinical Operations
Grant LaHay, B.A., CHRL
Executive Director, Human Resources
Kevin Barber, Ph.D., M.S., RAC, PMP
Senior Vice President, Global Regulatory Strategy and Submissions
Dr. Henry Castro, M.D.
Vice President, Global Clinical Development and Medical Affairs
Jeff Wiley, B.Sc.
Executive Director, Clinical Operations
Dean Rutty, M.Sc.
Vice President, Biometrics
Ambrose Kwok, Ph.D.
Vice President, Biometrics
Kirk Bateman, M.Sc.
Vice President, Biometrics
Sherryl Baker, Ph.D.
Vice President, Biometrics
Ming Liu, M.Sc.
Executive Director, Statistical Programming
Ivan Pessotto, H.BSc., B.Comm.
Executive Director, Clinical Data Management
Chris Ingle, B.Sc., CCRP
Executive Director, Clinical Data Management
Don Song, MD, Ph.D.
Senior Director, Clinical Data Management
Lisa Grierson, Ph.D.
Senior Director, Medical Writing and Clinical Safety Monitoring
Lukasz Niedzielski, B.Sc., Executive MBA
Vice President, Project Finance and Business Operations
Gergana Kukundjieva, M.Sc., Executive MBA
Executive Director, Europe Operations
Maria Russeva-Vitanova, Ph.D.
Senior Director, Clinical Operations
Chris K. Southard, M.A.
Executive Director, Project Management
Nina Chan, B.N.Sc., B.A., R.N.
Senior Director, Project Management
Aniko Kalo, B.Sc.
Senior Director, Project Management
Brian Wettlaufer, M.Sc.
Senior Director, Business Planning and Operations
Sandra Dinescu, Hon. B.Sc.
Senior Director, Quality Assurance and Compliance
Jeremy Baldwin, B.C.S., BComm
Senior Director, Information Technology
Build Your Career at Everest
We foster a culture where talent is valued, growth is encouraged, and contributions are recognized and rewarded. With an employee retention rate of 94%, we’re proud to be a place where employees choose to build lasting careers.
News from Everest Clinical Research
Who Should Own Your Clinical Study URL? A Practical Guide for Sponsors
It sounds like a small administrative detail—but in practice, URL ownership shapes how your trial operates from day one through closeout. It can influence everything from study startup timelines to change control processes, migration costs, and long-term data governance.
Everest Clinical Research and the Friedreich’s Ataxia Research Alliance (FARA) Announce Biostatistics Partnership to Advance Research in Friedreich’s Ataxia
TORONTO and PHILADELPHIA — February 27, 2026 —Everest Clinical Research and the Friedreich’s Ataxia Research Alliance (FARA)…
Everest Clinical Research to Expand Asia Pacific Operations with New Biometrics Team in the Philippines
Expansion will strengthen global biometrics delivery and support continued growth across the globe TORONTO — February 3,…